| Literature DB >> 35229410 |
Ángel Arturo López-González1,2, Zoe Manzanero3, Hilda María González San Miguel1, Sebastiana Arroyo Bote1, Pere Riutord Sbert1, María Del Mar Rigo Vives1, José Ignacio Ramírez Manent2.
Abstract
BACKGROUND ANDEntities:
Keywords: atherogenic index; cardiovascular disease; cleaning staff; hypertension; obesity
Mesh:
Year: 2022 PMID: 35229410 PMCID: PMC8886290 DOI: 10.1002/1348-9585.12320
Source DB: PubMed Journal: J Occup Health ISSN: 1341-9145 Impact factor: 2.570
Characteristics of people
| Women | Men | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Hotel housekeeper | Cleaning staff | Hotel housekeeper | Cleaning staff | |||
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
| Age | 43.2 (10.6) | 45.1 (10.5) | <.0001 | 35.9 (11.3) | 39.4 (11.9) | <.0001 |
| Height | 160.0 (6.4) | 159.3 (6.4) | <.0001 | 173.1 (7.6) | 173.4 (7.1) | .347 |
| Weight | 66.5 (13.3) | 68.1 (14.5) | <.0001 | 76.6 (14.6) | 79.7 (15.4) | <.0001 |
| Waist | 74.2 (10.5) | 76.2 (10.6) | <.0001 | 82.7 (11.6) | 85.6 (11.5) | <.0001 |
| SBP | 121.1 (15.9) | 121.7 (17.3) | <.0001 | 124.7 (14.4) | 127.9 (15.5) | <.0001 |
| DBP | 74.2 (10.3) | 74.6 (11.0) | <.0001 | 75.7 (10.4) | 77.1 (10.9) | .002 |
| Total cholesterol | 195.6 (36.6) | 199.9 (37.6) | <.0001 | 183.2 (40.1) | 189.4 (40.6) | <.0001 |
| HDL‐c | 55.8 (7.4) | 54.2 (8.2) | <.0001 | 52.0 (8.9) | 49.7 (8.5) | <.0001 |
| LDL‐c | 122.7 (35.7) | 126.2 (36.4) | <.0001 | 110.4 (37.1) | 115.4 (37.7) | .001 |
| Triglycerides | 85.8 (45.3) | 98.3 (54.8) | <.0001 | 106.9 (88.4) | 125.0 (97.7) | <.0001 |
| Glucose | 90.8 (15.7) | 90.8 (18.8) | .989 | 90.7 (21.0) | 92.9 (21.7) | .016 |
| AST | 22.3 (12.7) | 22.1 (13.9) | .135 | 29.1 (15.4) | 31.6 (23.1) | .007 |
| ALT | 19.9 (9.0) | 19.7 (8.5) | .370 | 23.7 (9.8) | 25.6 (14.0) | .009 |
| GGT | 21.9 (22.5) | 23.3 (22.6) | <.0001 | 28.5 (21.9) | 36.8 (48.9) | <.0001 |
Abbreviations: ALT, Alanine Aminotransferase; AST, Aspartate Aminotransferase; DBP, Diastolic blood pressure; GGT, Gamma‐glutamyl Transpeptidase; HDL‐c, High‐density lipoprotein cholesterol; LDL, Low‐density lipoprotein cholesterol; SBP, Systolic blood pressure.
Differences in mean values of the scales related to cardiovascular risk according to the profession by sex using the T‐Student test
| Women | Men | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Hotel housekeeper | Cleaning staff | Hotel housekeeper | Cleaning staff | |||
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
| Waist‐to‐height ratio (WtHR) | 0.46 (0.06) | 0.48 (0.06) | <.0001 | 0.48 (0.1) | 0.49 (0.1) | <.0001 |
| Body mass index (BMI) | 26.0 (4.9) | 26.8 (5.4) | <.0001 | 25.5 (4.4) | 26.5 (4.8) | <.0001 |
| CUN BAE | 36.7 (6.6) | 38.0 (6.9) | <.0001 | 23.2 (7.1) | 25.0 (7.2) | <.0001 |
| ECORE‐BF | 36.6 (6.9) | 38.0 (7.2) | <.0001 | 23.3 (6.6) | 25.0 (6.8) | <.0001 |
| Relative fat mass | 32.2 (5.5) | 33.5 (5.4) | <.0001 | 21.4 (5.5) | 22.8 (5.3) | <.0001 |
| Palafolls formula | 39.5 (5.2) | 40.3 (5.7) | <.0001 | 28.6 (4.6) | 29.6 (5.0) | <.0001 |
| Deurenberg formula | 35.7 (6.6) | 37.2 (7.2) | <.0001 | 22.7 (6.3) | 24.6 (6.9) | <.0001 |
| Body fat index | 26.6 (7.8) | 28.1 (7.9) | <.0001 | 20.10 (8.4) | 22.0 (8.4) | <.0001 |
| Body surface index | 50.9 (7.7) | 52.0 (8.4) | <.0001 | 55.3 (8.0) | 57.0 (8.4) | <.0001 |
| Normalized weight‐adjusted index | 0.6 (1.3) | 0.9 (1.4) | <.0001 | 0.3 (1.3) | 0.6 (1.5) | <.0001 |
| Body roundness index | 2.8 (1.2) | 3.0 (1.2) | <.0001 | 3.0 (1.1) | 3.3 (1.2) | <.0001 |
| Body shape index | 0.067 (0.01) | 0.068 (0.01) | <.0001 | 0.073 (0.01) | 0.074 (0.01) | .003 |
| Visceral adiposity index | 2.6 (1.5) | 3.1 (2.0) | <.0001 | 5.8 (5.3) | 7.5 (7.0) | <.0001 |
| Conicity index | 1.06 (0.1) | 1.07 (0.1) | <.0001 | 1.14 (0.1) | 1.16 (0.1) | <.0001 |
| No factors metabolic syndrome NCEP ATPIII | 1.0 (1.1) | 1.3 (1.2) | <.0001 | 1.0 (1.0) | 1.3 (1.2) | <.0001 |
| No factors metabolic syndrome JIS | 1.1 (1.2) | 1.4 (1.3) | <.0001 | 1.4 (1.2) | 1.7 (1.3) | <.0001 |
| Total cholesterol/HDL‐c | 3.6 (0.8) | 3.8 (1.0) | <.0001 | 2.2 (2.0) | 2.7 (2.4) | <.0001 |
| log triglycerides/HDL‐c | 0.15 (0.2) | 0.22 (0.2) | <.0001 | 0.24 (0.23) | 0.33 (0.3) | <.0001 |
| LDL‐c/HDL‐c | 2.3 (0.8) | 2.4 (0.9) | <.0001 | 2.2 (0.9) | 2.4 (1.0) | <.0001 |
| Total cholesterol‐HDL‐c | 139.8 (37.8) | 145.8 (39.1) | <.0001 | 131.3 (41.5) | 139.7 (42.5) | <.0001 |
| Cardiometabolic index | 0.7 (0.5) | 0.9 (0.7) | <.0001 | 1.1 (1.0) | 1.4 (1.3) | <.0001 |
| Triglyceride glucose index (TyG index) | 8.1 (0.5) | 8.3 (0.5) | <.0001 | 8.3 (0.6) | 8.5 (0.6) | <.0001 |
| TyG index‐BMI | 212.5 (45.8) | 223.0 (51.8) | <.0001 | 212.4 (44.1) | 225.3 (49.3) | <.0001 |
| TyG index‐waist circumference | 606.4 (99.9) | 632.4 (106.6) | <.0001 | 686.9 (116.5) | 726.8 (124.5) | <.0001 |
| TyG index‐WtHR | 3.8 (0.6) | 4.0 (0.7) | <.0001 | 4.0 (0.6) | 4.2 (0.7) | <.0001 |
| Waist triglyceride index | 72.7 (42.0) | 86.0 (53.4) | <.0001 | 100.8 (84.1) | 123.2 (99.8) | <.0001 |
| Waist weight index | 9.1 (0.7) | 9.3 (0.7) | <.0001 | 9.5 (0.7) | 9.6 (0.8) | <.0001 |
| ALLY vascular age SCORE | 5.1 (5.3) | 5.2 (5.2) | .044 | 6.9 (6.5) | 7.9 (6.9) | .030 |
| SCORE scale | 0.66 (1,1) | 0.68 (1.1) | .062 | 1.44 (2.0) | 1.82 (2.3) | .011 |
| ALLY vascular age Framingham | 2.9 (12.8) | 5.0 (13.7) | <.0001 | 4.6 (9.4) | 7.3 (10.4) | <.0001 |
| REGICOR scale | 2.7 (2.2) | 3.1 (2.3) | <.0001 | 2.9 (2.0) | 3.5 (2.3) | <.0001 |
| ERICE scale | 3.4 (3.8) | 3.9 (4.1) | <.0001 | 3.5 (4.0) | 4.8 (5.2) | <.0001 |
| Fatty liver index | 18.8 (21.0) | 24.3 (24.3) | <.0001 | 29.0 (25.4) | 36.9 (28.4) | <.0001 |
| Hepatic steatosis index | 37.2 (7.1) | 38.3 (6.9) | <.0001 | 37.7 (6.9) | 37.2 (7.3) | .530 |
| Zhejiang University index | 37.6 (5.7) | 38.9 (6.4) | <.0001 | 37.6 (6.0) | 37.3 (5.8) | .711 |
| Fatty liver disease | 30.7 (5.5) | 31.8 (6.1) | <.0001 | 32.4 (5.6) | 32.2 (5.6) | .738 |
| Lipid accumulation product | 16.5 (15.9) | 21.6 (21.12) | <.0001 | 22.3 (24.8) | 31.3 (34.6) | <.0001 |
Abbreviations: ALLY, Avoidable lost life years; CUN BAE, Clinica Universitaria Navarra Body Adiposity Estimator; ECORE‐BF, Equation Córdoba for Estimation of Body Fat; HDL‐c, High‐density lipoprotein cholesterol; LDL, Low‐density lipoprotein cholesterol; REGICOR, REgistre GIroni del COR; SCORE, Systematic COronary Risk Evaluation.
Differences in the prevalence of altered values of different scales related with cardiovascular risk according to the profession by sex using the chi‐square test
| Women | Men | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Hotel housekeeper | Cleaning staff | Hotel housekeeper | Cleaning staff | |||
| % (CI 95%) | % (CI 95%) | % (CI 95%) | % (CI 95%) | |||
| Waist‐to‐height ratio >0.50 | 23.4 (23.2–23.6) | 29.6 (29.4–29.8) | <.0001 | 32.7 (32.0–33.4) | 42.2 (41.4–43.1) | <.0001 |
| Body mass index obesity | 18.9 (18.7–19.1) | 24.0 (23.8–24.2) | <.0001 | 13.8 (13.2–14.4) | 20.8 (20.1–21.5) | <.0001 |
| CUN BAE obesity | 58.8 (58.5–59.2) | 65.7 (65.3–66.1) | <.0001 | 40.6 (39.6–41.6) | 49.3 (48.2–50.4) | <.0001 |
| ECORE‐BF obesity | 57.4 (57.1–57.7) | 64.1 (63.8–64.4) | <.0001 | 40.5 (39.6–41.5) | 49.0 (48.0–50.0) | <.0001 |
| Relative fat mass obesity | 36.0 (35.8–36.2) | 45.7 (45.5–45.9) | <.0001 | 40.2 (39.3–41.2) | 51.6 (50.5–52.7) | <.0001 |
| Palafolls formula obesity | 80.7 (80.4–81.1) | 83.9 (83.5–84.3) | <.0001 | 76.1 (74.0–78.2) | 82.5 (80.0–85.0) | <.0001 |
| Deurenberg formula obesity | 80.3 (80.0–80.6) | 84.9 (84.5–85.5) | <.0001 | 35.3 (34.4–36.2) | 45.9 (44.9–46.9) | <.0001 |
| Hypertension | 17.0 (16.8–17.2) | 23.2 (23.0–23.4) | <.0001 | 19.1 (18.3–19.9) | 28.4 (27.4–29.4) | <.0001 |
| Total cholesterol ≥200 mg/dl | 43.1 (42.7–43.5) | 48.3 (48.0–48.7) | <.0001 | 31.8 (30.7–33.0) | 37.2 (36.2–38.4) | .007 |
| LDL‐c ≥ 130 mg/dl | 39.4 (39.1–39.7) | 44.2 (43.8–44.6) | <.0001 | 28.4 (27.4–29.5) | 34.1 (33.0–35.2) | .003 |
| Triglycerides ≥150 mg/dl | 7.1 (7.0–7.3) | 11.8 (11.6–12.0) | <.0001 | 17.8 (16.9–18.7) | 23.9 (22.9–24.9) | .001 |
| Glycemia 100–125 mg/dl | 15.7 (15.5–15.9) | 15.0 (14.8–15.2) | <.0001 | 14.1 (13.4–14.8) | 18.4 (17.6–19.2) | <.0001 |
| Glycemia ≥126 mg/dl | 2.1 (1.9–2.2) | 2.6 (2.5–2.7) | <.0001 | 2.2 (1.9–2.5) | 3.6 (3.3–3.9) | <.0001 |
| Metabolic syndrome NCEP ATPIII | 11.9 (11.7–12.1) | 17.0 (16.8–17.2) | <.0001 | 9.3 (8.6–10.0) | 17.6 (16.8–18.5) | <.0001 |
| Metabolic syndrome IDF | 11.1 (10.9–11.3) | 15.5 (15.3–15.7) | <.0001 | 5.6 (5.3–5.9) | 14.1 (13.7–14.5) | <.0001 |
| Metabolic syndrome JIS | 14.0 (13.8–14.2) | 19.6 (19.4–19.8) | <.0001 | 16.4 (15.9–16.9) | 28.5 (27.8–29.3) | <.0001 |
| Atherogenic dyslipidemia | 3.5 (3.4–3.6) | 7.1 (7.0–7.2) | <.0001 | 4.8 (4.4–5.2) | 8.3 (7.6–9.0) | <.0001 |
| Lipid triad | 0.9 (0.8–0.9) | 2.1 (2.0–2.2) | <.0001 | 1.1 (1.0–1.2) | 2.3 (2.1–2.5) | <.0001 |
| Hypertriglyceridemic waist | 1.1 (1.0–1.1) | 2.5 (2.2.4–2.6) | <.0001 | 3.9 (3.6–4.2) | 8.3 (7.9–8.7) | <.0001 |
| Total cholesterol/HDL‐c moderate‐high | 13.7 (13.6–13.8) | 20.5 (20.4–20.6) | <.0001 | 11.6 (11.0–12.2) | 17.3 (16.6–18.0) | .001 |
| log triglycerides/HDL‐c high | 6.5 (6.4–6.6) | 11.6 (11.5–11.7) | <.0001 | 19.5 (18.8–20.2) | 27.0 (26.5–27.5) | <.0001 |
| LDL‐c/HDL‐c high | 16.4 (16.3–16.5) | 21.7 (21.6–21.8) | <.0001 | 18.6 (18.2–19.0) | 26.3 (25.7–26.9) | <.0001 |
| Total cholesterol‐HDL‐c high | 58.9 (58.7–59.2) | 65.2 (65.0–65.5) | <.0001 | 48.8 (47.7–49.9) | 57.2 (56.0–58.4) | <.0001 |
| SCORE scale moderate‐high | 6.7 (6.6–6.8) | 7.1 (7.0–7.2) | <.0001 | 15.5 (14.9–16.1) | 23.8 (23.0–24.6) | <.0001 |
| REGICOR scale moderate‐high | 17.3 (17.1–17.5) | 20.6 (20.4–20.8) | <.0001 | 21.1 (20.4–21.8) | 28.5 (27.6–29.4) | <.0001 |
| ERICE scale moderate‐high | 4.6 (4.5–4.7) | 6.1 (6.0–6.2) | <.0001 | 7.3 (6.9–7.7) | 14.9 (14.4–15.4) | <.0001 |
| Fatty liver index high risk | 7.2 (7.1–7.3) | 11.7 (11.6–11.8) | <.0001 | 15.8 (15.3–16.3) | 24.0 (23.4–24.6) | <.0001 |
| Hepatic steatosis index high risk | 50.2 (50.0–50.4) | 58.1 (57.9–58.3) | <.0001 | 52.3 (51.1–53.5) | 55.9 (54.6–57.3) | .034 |
| Zhejiang University index high risk | 41.3 (41.0–41.5) | 48.8 (48.6–49.0) | <.0001 | 38.4 (37.5–39.3) | 39.5 (38.5–40.5) | .127 |
| Fatty liver disease high risk | 51.7 (51.4–52.1) | 52.0 (51.7–52.3) | <.0001 | 53.1 (51.8–54.4) | 58.4 (57.0–59.8) | .001 |
Abbreviations: CUN BAE, Clinica Universitaria Navarra Body Adiposity Estimator; ECORE‐BF, Equation Córdoba for Estimation of Body Fat; HDL‐c, High‐density lipoprotein cholesterol; LDL, Low‐density lipoprotein cholesterol; REGICOR, REgistre GIroni del COR; SCORE, Systematic COronary Risk Evaluation.
Logistic regression analysis to examine the relationship between covariates (≥50 years, male, cleaning staff, and smoker) and different cardiometabolic scales
| ≥ 50 years | Male | Cleaning staff | Smoker | |
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| WtHR <0.50 | 1 | 1 | 1 | 1 |
| WtHR ≥0.50 | 1.12 (1.07–1.17) | 1.75 (1.66–1.86) | 1.38 (1.32–1.44) | 0.93 (0.89–0.97) |
| BMI nonobesity | 1 | 1 | 1 | 1 |
| BMI obesity | 1.22 (1.16–1.28) | 0.84 (0.79–0.90) | 1.35 (1.28–1.41) | 0.92 (0.88–0.96) |
| CUN BAE nonobesity | 1 | 1 | 1 | 1 |
| CUN BAE obesity | 3.46 (3.31–3.62) | 0.58 (0.55–0.61) | 1.27 (1.21–1.32) | 0.94 (0.90–0.98) |
| RFM nonobesity | 1 | 1 | 1 | 1 |
| RFM obesity | 1.17 (1.13–1.22) | 1.29 (1.22–1.36) | 1.49 (1.43–1.55) | 0.93 (0.89–0.96) |
| Deurenberg formula nonobesity | 1 | 1 | 1 | 1 |
| Deurenberg formula obesity | 12.20 (11.16–13.34) | 0.15 (0.14–0.16) | 1.27 (1.21–1.34) | 0.94 (0.89–0.99) |
| Nonhypertension | 1 | 1 | 1 | 1 |
| Hypertension | 3.67 (3.50–3.85) | 1.65 (1.55–1.77) | 1.38 (1.31–1.45) | ns |
| Total cholesterol <200 mg/dl | 1 | 1 | 1 | 1 |
| Total cholesterol ≥200 mg/dl | 3.47 (3.33–3.61) | 0.74 (0.70–0.79) | 1.15 (1.11–1.20) | ns |
| LDL‐c < 130 mg/dl | 1 | 1 | 1 | 1 |
| LDL‐c ≥ 130 mg/dl | 3.36 (3.22–3.50) | 0.76 (0.72–0.81) | 1.14 (1.09–1.18) | ns |
| Triglycerides <150 mg/dl | 1 | 1 | 1 | 1 |
| Triglycerides ≥150 mg/dl | 2.03 (1.91–2.16) | 2.72 (2.53–2.92) | 1.63 (1.53–1.74) | ns |
| Glycemia <126 mg/dl | 1 | 1 | 1 | 1 |
| Glycemia ≥126 mg/dl | 3.03 (2.90–3.18) | 1.38 (1.30–1.48) | ns | ns |
| Nonmetabolic syndrome NCEP ATPIII | 1 | 1 | 1 | 1 |
| Metabolic syndrome NCEP ATPIII | 3.06 (2.90–3.22) | 1.23 (1.14–1.33) | 1.44 (1.36–1.52) | ns |
| Nonmetabolic syndrome IDF | 1 | 1 | 1 | 1 |
| Metabolic syndrome IDF | 2.01 (1.91–2.12) | ns | 1.42 (1.34–1.50) | ns |
| Nonmetabolic syndrome JIS | 1 | 1 | 1 | 1 |
| Metabolic syndrome JIS | 3.09 (2.94–3.25) | 1.97 (1.85–2.11) | 1.43 (1.35–1.50) | ns |
| Nonatherogenic dyslipidemia | 1 | 1 | 1 | 1 |
| Atherogenic dyslipidemia | 2.33 (2.15–2.52) | 1.38 (1.24–1.53) | 1.98 (1.81–2.17) | ns |
| Nonlipid triad | 1 | 1 | 1 | 1 |
| Lipid triad | 3.31 (2.84–3.84) | 1.34 (1.11–1.63) | 2.11 (1.77–2.50) | ns |
| Total cholesterol/HDL‐c normal | 1 | 1 | 1 | 1 |
| Total cholesterol/HDL‐c high | 3.37 (3.21–3.54) | ns | 1.52 (1.45–1.60) | 0.94 (0.89–0.99) |
| log Triglycerides/HDL‐c normal | 1 | 1 | 1 | 1 |
| log Triglycerides/HDL‐c high | 2.20 (2.07–2.33) | 3.36 (3.13–3.60) | 1.75 (1.64–1.88) | ns |
| LDL‐c/HDL‐c normal | 1 | 1 | 1 | 1 |
| LDL‐c/HDL‐c high | 3.36 (3.20–3.52) | 1.56 (1.46–1.67) | 1.35 (1.28–1.41) | ns |
| SCORE scale low | 1 | 1 | 1 | 1 |
| SCORE scale moderate‐high | 110.00 (84.07–143.91) | 13.01 (11.38–14.86) | 1.11 (1.06–1.17) | 7.12 (6.45–7.87) |
| REGICOR scale low | 1 | 1 | 1 | 1 |
| REGICOR scale moderate‐high | 19.32 (17.84–20.92) | 1.65 (1.50–1.82) | 1.14 (1.07–1.21) | 1.89 (1.78–2.02) |
| Fatty liver index low‐moderate risk | 1 | 1 | 1 | 1 |
| Fatty liver index high risk | 1.24 (1.15–1.32) | 2.47 (2.28–2.67) | 1.69 (1.58–1.82) | ns |
| Hepatic steatosis index low‐moderate risk | 1 | 1 | 1 | 1 |
| Hepatic steatosis index high risk | 1.54 (1.39–1.72) | 0.86 (0.76–0.97) | 1.30 (1.16–1.47) | ns |
| Zhejiang University index low risk | 1 | 1 | 1 | 1 |
| Zhejiang University index high risk | 1.64 (1.47–1.82) | 0.76 (0.67–0.86) | 1.28 (1.14–1.45) | ns |
| Fatty liver disease normal risk | 1 | 1 | 1 | 1 |
| Fatty liver disease high risk | 1.32 (1.18–1.47) | 1.36 (1.20–1.54) | ns | ns |
Abbreviations: BMI, body mass index; CUN BAE, Clinica Universitaria Navarra Body Adiposity Estimator; REGICOR, REgistre GIroni del COR. ns nonsignificance; RFM, relative fat mass; SCORE, Systematic COronary Risk Evaluation; WtHR, Waist‐to‐Height ratio.